Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 10;20:27. doi: 10.1186/s12885-019-6498-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2020

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 2a-c — The immune-markers SSTR-2a, p53 and CgA in relation to origin of primary tumour and Ki67. a: Percentages for each marker is shown beneath each bar. For SSTR-2a, p53 and CgA the number of patients for upper GI is 38, for lower GI 64, for pancreas 28 and for CUP 33; except for p53, which are 32 due to one missing analysis. Differences in distribution of the immune-markers are visualised according to primary tumour. b: The distribution of immunomarkers for the specific localisation of the primary tumor is presented. c: The Ki67-index compared to the staining pattern of p53, SSTR-2a and CgA